Nobuhiro Nakano

Dr. Nobuhiro Nakano

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2007 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
FNFrançois Niyonsaba
François Niyonsaba
HUHiroko Ushio
Hiroko Ushio
NNNobuhiro Nakano
Nobuhiro Nakano
WNWilliam Ng
William Ng
KSKoji Sayama
Koji Sayama
HOHideoki Ogawa
Hideoki Ogawa

7 October 2012 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
THTomomitsu Hirota
Tomomitsu Hirota
ATAtsushi Takahashi
Atsushi Takahashi
MKMichiaki Kubo
Michiaki Kubo
TTTatsuhiko Tsunoda
Tatsuhiko Tsunoda
KTKaori Tomita
Kaori Tomita
MTMayumi Tamari
Mayumi Tamari

17 February 2011 in Blood
Verified
Journal Article
Closed access
PDF file
SKShunsuke Kanada
Shunsuke Kanada
CNChiharu Nishiyama
Chiharu Nishiyama
NNNobuhiro Nakano
Nobuhiro Nakano
RSRyuyo Suzuki
Ryuyo Suzuki
KMKeiko Maeda
Keiko Maeda
KOKo Okumura
Ko Okumura
In this study, we investigated the role of a transcription factor, PU.1, in the regulation of CD80 and CD86 expression in dendritic cells (DCs). A chromatin immunoprecipitation assay revealed that PU.1 is constitutively bound to the CD80 and CD86 promoters in bone marrow–derived DCs. In addition, co-expression of PU.1 resulted in the transactivation of the CD80 and CD86 promoters in a reporter assay. The binding of PU.1 to cis-enhancing regions was confirmed by electromobility gel-shift assay. As expected, inhibition of PU.1 expression by short interfering RNA (siRNA) in bone marrow–derived DCs resulted in marked down-regulation of CD80 and CD86 expression. Moreover, overexpression of PU.1 in murine bone marrow–derived lineage-negative cells induced the expression of CD80 and CD86 in the absence of monocyte/DC-related growth factors and/or cytokines. Based on these results, we conclude that PU.1 is a critical factor for the expression of CD80 and CD86. We also found that subcutaneous injection of PU.1 siRNA or topical application of a cream-emulsified PU.1 siRNA efficiently inhibited murine contact hypersensitivity. Our results suggest that PU.1 is a potential target for the treatment of immune-related diseases.

1 February 2014 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
YNYuki Nakamura
Yuki Nakamura
NNNobuhiro Nakano
Nobuhiro Nakano
KIKayoko Ishimaru
Kayoko Ishimaru
MHMutsuko Hara
Mutsuko Hara
TITakako Ikegami
Takako Ikegami
ANAtsuhito Nakao
Atsuhito Nakao

1 January 2005 in Bioscience, Biotechnology, and Biochemistry
Verified
Journal Article
Closed access
TTTomoko Tokura
Tomoko Tokura
NNNobuhiro Nakano
Nobuhiro Nakano
TITomonobu Ito
Tomonobu Ito
HMHironori Matsuda
Hironori Matsuda
YNYoko Nagasako-Akazome
Yoko Nagasako-Akazome
CNChiharu Nishiyama
Chiharu Nishiyama
Extracts from immature fruit of the apple (Rosaceae, Malus sp.), which contain procyanidins (polymers of catechins) as the major ingredients, are known to inhibit histamine release from mast cells. We analyzed in this study the mechanism for the anti-allergic activity of two polyphenol-enriched apple extracts. These extracts, termed “crude apple polyphenol (CAP)” and “apple condensed tannin (ACT)”, reduced the degranulation of mast cells caused by cross-linking of the high-affinity receptor for IgE (FcεRI) with IgE and the antigen in a dose-dependent manner. Furthermore, western blotting revealed that phosphorylation of the intracellular signal-transduction molecules caused by cross-linking of FcεRI was markedly decreased by the addition of CAP or ACT. We then analyzed the effects of CAP and ACT on the binding of the IgE antibody to FcεRI on mast cells, which is the first key step in the allergic reaction mediated by mast cells, and found that this binding was markedly inhibited by both CAP and ACT. These...

1 March 2012 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
NKNao Kitamura
Nao Kitamura
HYHokuto Yokoyama
Hokuto Yokoyama
TYTakuya Yashiro
Takuya Yashiro
NNNobuhiro Nakano
Nobuhiro Nakano
MNMakoto Nishiyama
Makoto Nishiyama
CNChiharu Nishiyama
Chiharu Nishiyama